• Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study

    Tuesday April 5th 2022

  • Aligos Therapeutics selects drug candidate ALG-097558, a potent ritonavir-free oral protease inhibitor for the treatment and prevention of COVID-19

    Tuesday April 5th 2022

  • Rejuvenate Biomed started a groundbreaking clinical trial and expands for future growth

    Tuesday March 29th 2022

  • Bone Therapeutics to strategically focus on lead cell therapy product ALLOB

    Tuesday March 29th 2022

  • Jyseleca® approved in Japan for ulcerative colitis

    Monday March 28th 2022

  • argenx announces positive topline Phase 3 data from ADAPT-SC study evaluating subcutaneous efgartigimod for generalized myasthenia gravis

    Tuesday March 22nd 2022

  • Confo Therapeutics doses first subjects in Phase 1 clinical trial of CFTX-1554 for the treatment of neuropathic pain

    Thursday March 10th 2022

  • miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study

    Thursday February 17th 2022

  • Your news here?

  • UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results

    Friday February 4th 2022

  • Large UK study shows rapid EGFR testing with Idylla™ alongside NGS has potential to enhance lung cancer patient health outcomes

    Tuesday January 25th 2022

  • Mithra announces positive top-line results from Donesta® Phase 3 studies in menopausal women

    Friday January 14th 2022


Strategic Partners